HB940 is an appropriations bill for the University of Hawaii at Hilo. As drafted, it would allocate an unspecified amount of general funds for fiscal years 2025-2026 and 2026-2027 to support the rat lungworm lab, also known as the Jarvi Lab, housed in the Daniel K. Inouye College of Pharmacy. The bill directs the University of Hawaii to expend the funds for the purposes of the act.
The measure is narrowly focused on funding a specific research facility rather than changing regulatory policy or creating a new program. It identifies the lab by both its common name and alternate name, and it is framed as a state general-fund appropriation for university research related to rat lungworm disease. The bill also contains an unusual effective date of July 1, 3000, which is commonly used in placeholder drafting and suggests the measure may be a draft or placeholder version pending final amendment.
Impact
If enacted, HB940 would add a new state general-fund appropriation for the University of Hawaii at Hilo, specifically supporting the rat lungworm lab at the Daniel K. Inouye College of Pharmacy. It would not amend substantive statutes governing health, higher education, or research oversight, but it would affect the state budget by authorizing funding for a university research program. The practical impact would be to sustain or expand research capacity on rat lungworm disease, a public health issue relevant to Hawaii.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available record. Based on the bill text alone, the measure appears technical and supportive of university research, with an emphasis on public health and academic funding. The absence of recorded controversy suggests either limited discussion in the provided materials or that the bill had not yet advanced to a stage with documented floor or committee action.
Contention
The main potential point of contention is fiscal: the bill would draw from general revenues for an unspecified appropriation amount, which may prompt questions about budget priorities and the size of the funding request. Another possible issue is the specificity of the appropriation, since it directs funds to a single lab at a single campus rather than a broader research initiative. No explicit opposition, amendments, or disputed policy issues are reflected in the materials provided.